# Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients

> **NCT01823510** · PHASE4 · COMPLETED · sponsor: **Juan J Badimon** · enrollment: 20 (actual)

## Conditions studied

- Type-2 Diabetes Mellitus
- Coronary Artery Disease

## Interventions

- **DRUG:** Ticagrelor + Aspirin
- **DRUG:** Clopidogrel + Aspirin

## Key facts

- **NCT ID:** NCT01823510
- **Lead sponsor:** Juan J Badimon
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2016-05-10
- **Final completion:** 2016-05-10
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2017-12-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01823510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01823510, "Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01823510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*